Word

VIVA

Status

Dead

Status Code

606

Status Date

Monday, July 18, 2022

Serial Number

90026492

Mark Type

5000

Filing Date

Monday, June 29, 2020

Published for Opposition

Tuesday, April 20, 2021

Abandoned Date

Monday, July 18, 2022

Trademark Owner History

Viva Biotech (Shanghai) Limited - Owner At Publication

Classifications

9 Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Scientific apparatus, namely, cellular mixed ester membranes for use in the science and research industry; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; Laboratory chemical reactors; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics, and contaminants; Portable detection and identification instruments using light sources and light detectors for detecting and identifying chemical and biological substances not for medical purposes; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and computer systems for use in protein purification; Laboratory apparatus and instruments for extracting protein, not for medical purposes; Laboratory apparatus and instruments for extracting DNA, not for medical purposes; Solid phase extraction cartridges for laboratory use; Chromatography apparatus for laboratory use

35 Pharmaceutical cost management services and drug utilization review services; Providing an online computer database for collecting and reporting controlled substance prescription drug dispensing information for business purposes; Online retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, via in-store order pickup; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

1 Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Chemicals for use in the purification of proteins for in vitro use; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Protein in raw material form for scientific and medical research; Protein arrays and nucleotide arrays for scientific and medical research; Chemical preparations for scientific purposes; Stem cells for research or scientific purposes; Enzymes for use in protein hydrolysis; Chromatography chemicals; Electrophoresis gels; Electrophoresis gels other than for medical or veterinary purposes

44 Medical equipment rental; Performing diagnosis of diseases; Medication consultation; Medical consultation; Medical auxiliary services being medical services; Medical services; Chemotherapy services; Stem cell treatment services; Medical clinic services; Medical treatment of cancer; Human tissue bank services; Genetic screening for medical purposes; Genetic testing for medical purposes; Medical analysis services for cancer diagnosis; Human blood collection and preservation; Medical analysis services provided by medical laboratories for diagnosis and treatment purposes

42 Drug evaluation, namely, pharmaceutical product evaluation; Drug research services, namely, pharmaceutical research services; drug discovery services; implementation of early evaluations in the field of new drugs; scientific investigations for medical purposes; scientific laboratory services; laboratory equipment and instrument rental; chemical analysis services; biochemical research and analysis; Chemical research and analysis; Scientific research on the mechanism of action of compound use in animals; development and testing of chemical production methods; chemical analysis; chemical synthesis evaluation services; medical research; medical laboratory services; genome structure and function analysis; stem cell research services; Blood analysis services; Biotechnology research services; medical research services; biomedical research services; Genetic screening for scientific research purposes; antibody research and development; genetic testing for scientific research purposes; development of pharmaceutical preparations and medicines; Conducting clinical trials for others; Drug testing, namely, testing of pharmaceuticals; Chemical testing; Functional testing of equipment and instruments; Information technology consulting services in the field of drug discovery; Cloud computing services featuring software for performing drug discovery processess; Computer programming for medical care

The mark consists of the text "VIVA" in stylized lettering.
Color is not claimed as a feature of the mark.

Trademark Events

Jul 18, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 18, 2022

Abandonment - No Use Statement Filed

Dec 16, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 14, 2021

Sou Extension 1 Granted

Dec 14, 2021

Sou Extension 1 Filed

Dec 14, 2021

Sou Teas Extension Received

Jun 15, 2021

Noa E-Mailed - Sou Required From Applicant

Apr 20, 2021

Official Gazette Publication Confirmation E-Mailed

Apr 20, 2021

Published For Opposition

Mar 31, 2021

Notification Of Notice Of Publication E-Mailed

Mar 18, 2021

Approved For Pub - Principal Register

Mar 10, 2021

Teas/Email Correspondence Entered

Mar 10, 2021

Correspondence Received In Law Office

Mar 9, 2021

Assigned To Lie

Dec 6, 2020

Teas Response To Office Action Received

Sep 30, 2020

Notification Of Non-Final Action E-Mailed

Sep 30, 2020

Non-Final Action E-Mailed

Sep 30, 2020

Non-Final Action Written

Sep 30, 2020

Assigned To Examiner

Jul 26, 2020

New Application Office Supplied Data Entered

Jul 2, 2020

New Application Entered